Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hisata (Tochigi, Japan), M. Bando (Tochigi, Japan), S. Homma (Tokyo, Japan), K. Kataoka (Aichi, Japan), T. Ogura (Kanagawa, Japan), S. Izumi (Tokyo, Japan), S. Sakamoto (Tokyo, Japan), Y. Saito (Tokyo, Japan), K. Watanabe (Kyoto, Japan), Y. Shimizu (Tochigi, Japan), M. Kato (Tokyo, Japan), N. Inase (Tokyo, Japan). Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan. 1847

Member's Comments

No comment yet.

Related content which might interest you: BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Triple Therapy Pathways: A Multi-Country, Retrospective Observational Study in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Management of airway diseases in primary care Year: 2019 Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Monitored Anesthesia Care with Dexmedetomidine in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function. A Prospective, Single-center Study. Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 Exploring Efficacy and Safety of Oral Pirfenidone for Progressive, non-IPF Lung Fibrosis (RELIEF-Study) Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017 Feasibility and Safety of Pleuroscopic Cryobiopsy of the Pleura: A Prospective Study Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS) Year: 2017 Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Home Noninvasive Ventilation with Built-in Software in Chronic Hypercapnic COPD Patients: a Mid-term Prospective, Multicenter, Randomized, Controlled Trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 The ARROW Study: A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Study of Selonsertib in Subjects with Pulmonary Arterial Hypertension Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Anatomical and Functional Repercussions of Sequelae of Pulmonary Tuberculosis: Cross-Sectional Observational Study Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 High Flow Nasal Oxygen Therapy Usage in the Adult Intensive Care Units in Turkey: Multi-center, Prospective Study Source: International Congress 2019 – Recent developments in intensive care unit medicine Year: 2019 Late Breaking Abstract - Safety and Performance of Total Lung Access to Peripheral Nodules in prospective, multi-center study Source: International Congress 2019 – Interventional pulmonology: a mixture of spices Year: 2019 Pirfenidone post-authorization safety registry (PASSPORT) – Interim analysis of IPF treatment Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Adherence to Home Mechanical Ventilation over 10-Years:A Retrospective, Single-Centre Cohort Study Source: Virtual Congress 2020 – Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects Year: 2020